Literature DB >> 183518

High dose urography: incidence and relationship to spontaneous peripelvic extravasation.

M E Bernardino, B L Clennan.   

Abstract

A prospective study was undertaken to determine the incidence of spontaneous extravasation of contrast in 82 patients with acute renal colic. The extravasation rate among 37 patients receiving 75 ml of contrast was 8.1%, while the rate among 45 patients receiving either 300 ml of 30% solution by infusion or a 140 ml bolus dose was 24.4%; overall the rate was 17%. Thus the incidence of extravasation was shown to increase with higher doses of contrast media. The primary dose in acute renal colic or other forms of obstructive uropathy should be in the low range (20-25 g 1-); reinjection after screening can be undertaken if necessary.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183518     DOI: 10.2214/ajr.127.3.373

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

Review 1.  Spontaneous (renal) pelvic rupture. Two cases cured by conservative therapy.

Authors:  S Csata; D Répássy; T Weninger; G Tamás
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Spontaneous rupture of an L-shaped kidney.

Authors:  E Szentgyörgyi
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Experimental study of the pressure-volume and pressure-time relations in the completely obstructed pelvis of the porcine kidney. Part 4: Instability and blow out.

Authors:  T K Donkervoort; G L van Rij
Journal:  Urol Res       Date:  1985

4.  Chronic pancreatitis as a cause of gastrointestinal bleeding.

Authors:  R I Hall; M I Lavelle; C W Venables
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

5.  Spontaneous bilateral renal pelvis rupture during CT in the absence of urinary tract obstruction: case report.

Authors:  Zongchen Li; Joey Chan Yiing Beh
Journal:  BMC Urol       Date:  2020-07-13       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.